The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Cerebrovascular disease with neurocognitive impairment

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9): 121‑130

DOI: 10.17116/jnevro2021121091121

Read: 4256 times

Download PDF (RU)
Contact the author
Table of contents

CEREBROVASCULAR DISEASE WITH NEUROCOGNITIVE IMPAIRMENT
CEREBROVASCULAR DISEASE WITH NEUROCOGNITIVE IMPAIRMENT

To cite this article:

Cerebrovascular disease with neurocognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9):121‑130. (In Russ.)
https://doi.org/10.17116/jnevro2021121091121

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18
Evaluation of the effe­ctiveness of the drug Cortexin in combination with the use of the application Apha­sia.No (Afaziyam.Net) in the correction of speech diso­rders in patients with cere­bral infa­rction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):147-151
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Clinical and epidemiological indi­cators of stroke during the COVID-19 pandemic and in the post-COVID period in the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):5-11
Inte­rnational multicenter randomized double-blind placebo-controlled study asse­ssing the effi­cacy and safety of sequential therapy with Mexi­dol and Mexi­dol FORTE 250 in patients with chro­nic brain ischemia (MEMO): suba­nalysis in patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2024;(10):72-83
Dyna­mics of motor and functional diso­rders in the early reco­very period after ischemic stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):13-22
Electromagnetic stimulation in diaphragm dysfunction: repe­titive peri­pheral magnetic stimulation as a method of choice during the reha­bilitation period after stroke. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):57-65
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11
Abstract:

In the International Classification of Diseases 11th revision in the section «Diseases of the nervous system», it is proposed to distinguish «Cerebrovascular disorder with neurocognitive impairment», which corresponds to both discirculatory encephalopathy (DEP) or chronic cerebral ischemia (CCI) accepted in our country, and also vascular cognitive impairments. The terminology, prevalence, risk factors and pathological basis of the disease are discussed, in particular multiple infarctions, strategic infarctions, cerebral small vessel disease, specific microangiopathies, intracerebral hemorrhage and global hypoperfusion. Post-stroke cognitive impairments are discussed in detail. The article presents relevant data on the pathogenesis of the disease, highlights the issues of clinical and neuroimaging diagnostics. Based on the data presented in the article, we can conclude that the diagnosis of DEP, CCI should be based on the presence of cerebrovascular disease with neurocognitive impairment, which implies the verification of vascular cognitive impairments and reliable neuroimaging signs of cerebrovascular pathology while excluding other causes. Early diagnosis and effective treatment of cerebrovascular disease with neurocognitive impairment (DEP, CCI) is becoming increasingly important, since treatment can slow the progression of the disease and lead to a decrease in the incidence of stroke and dementia.

Keywords:

discirculatory encephalopathy
chronic cerebral ischemia
stroke
vascular cognitive impairment

Received:

11.01.2021

Accepted:

18.05.2021

Close metadata

References:

  1. ICD-11 (International Classification of Diseases 11.  https://icd11.ru
  2. Gusev EI, Bogolepova AN. Kognitivnye narushenija pri cerebrovaskuljarnyh zabolevanijah. M.: MEDpress-inform; 2013. (In Russ.).
  3. Gusev EI, Chukanova EI. Modern pathogenetic aspects of development of cerebral chronic ischemia. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(3):4-8. (In Russ.). https://doi.org/10.17116/jnevro2015115314-8
  4. Jahno NN, Levin OS, Damulin IV. Comparison of clinical and MRI data in discirculatory encephalopathy. Message 2: cognitive impairment. Nevrologicheskij Zhurnal. 2001b;6(3):10. (In Russ.).
  5. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672-2713. https://doi.org/10.1161/STR.0b013e3182299496
  6. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P; Internationlal Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206-218.  https://doi.org/10.1097/WAD.0000000000000034
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).
  8. Skrobot OA, O’Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2017;13(6):624-633.  https://doi.org/10.1016/j.jalz.2016.10.007
  9. van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH, Scheltens P. Vascular cognitive impairment. Nat Rev Dis Primers. 2018;4:18003. https://doi.org/10.1038/nrdp.2018.3
  10. Wortmann M. Dementia: a global health priority — highlights from an ADI and World Health Organization report. Alzheimers Res Ther. 2012;4:40.  https://doi.org/10.1186/alzrt143
  11. Wu YT, Fratiglioni L, Matthews FE, Lobo A, Breteler MM, Skoog I, Brayne C. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15:116-124.  https://doi.org/10.1016/S1474-4422(15)00092-7
  12. Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011—2013. Alzheimers Dement. 2017;13(1):28-37.  https://doi.org/10.1016/j.jalz.2016.04.002
  13. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197-2204. https://doi.org/10.1212/01.wnl.0000271090.28148.24
  14. Kua EH, Ho E, Tan HH, Tsoi C, Thng C, Mahendran R. The natural history of dementia. Psychogeriatrics. 2014;14(3):196-201.  https://doi.org/10.1111/psyg.12053
  15. Staekenborg SS, Pijnenburg YA, Lemstra AW, Scheltens P, Vd Flier WM. Dementia and Rapid Mortality: Who is at Risk? J Alzheimers Dis. 2016;53(1):135-142.  https://doi.org/10.3233/JAD-151063
  16. Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 2000;54:447-451.  https://doi.org/10.1212/wnl.54.2.447
  17. Golovacheva VA, Parfenov VA, Tabeeva GR, Osipova VV, Smulevich AB, Andryushchenko AV, Golovacheva AA. The optimization of management of chronic daily headache patients. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(2):4-9. (In Russ.). https://doi.org/10.17116/jnevro2017117214-9
  18. Antonenko LM, Parfenov VA. A specialized approach to diagnosing and treating vertigo. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;(8)1:56-60. (In Russ.). https://dx.doi.org/10.14412/2074-2711-2016-1-56-60
  19. Parfenov VA, Zaharov VV, Preobrazhenskaja IS. Kognitivnye rasstrojstva. M.: Remedium; 2014. (In Russ.).
  20. Parfenov VA. Discirkuljatornaja jencefalopatija i sosudistye kognitivnye rasstrojstva. M.: IMA-PRESS; 2017. (In Russ.).
  21. Bogolepova AN. People’s knowledge about dementia. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(6):97-102. (In Russ.). https://doi.org/10.17116/jnevro20151156197-102
  22. Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(25):3326-3344. https://doi.org/10.1016/j.jacc.2019.04.034
  23. Dichgans M, Zietemann V. Prevention of vascular cognitive impairment. Stroke. 2012;43:3137-3146. https://doi.org/10.1161/STROKEAHA.112.651778
  24. Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain. 2016;139(11):2957-2969. https://doi.org/10.1093/brain/aww214
  25. Kulesh AA, Shestakov VV. Vascular cognitive impairment, no dementia: diagnosis, prognosis, treatment, and prevention. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):68-75. (In Russ.). https://doi.org/10.14412/2074-2711-2017-3-68-75
  26. Dichgans M, Leys D. Vascular Cognitive Impairment. Circ Res. 2017;120(3):573-591.  https://doi.org/10.1161/CIRCRESAHA.116.308426
  27. Zhao L, Biesbroek JM, Shi L, Liu W, Kuijf HJ, Chu WW, Abrigo JM, Lee RK, Leung TW, Lau AY, Biessels GJ, Mok V, Wong A. Strategic infarct location for post-stroke cognitive impairment: A multivariate lesion-symptom mapping study. J Cereb Blood Flow Metab. 2018;38(8):1299-1311. https://doi.org/10.1177/0271678X17728162
  28. Kulesh A, Drobakha V, Kuklina E, Nekrasova I, Shestakov V. Cytokine Response, Tract-Specific Fractional Anisotropy, and Brain Morphometry in Post-Stroke Cognitive Impairment. J Stroke Cerebrovasc Dis. 2018;27(7):1752-1759. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.02.004
  29. Aben HP, Biessels GJ, Weaver NA, Spikman JM, Visser-Meily JMA, de Kort PLM, Reijmer YD; PROCRAS Study Group. Extent to Which Network Hubs Are Affected by Ischemic Stroke Predicts Cognitive Recovery. Stroke. 2019;50(10):2768-2774. https://doi.org/10.1161/STROKEAHA.119.025637
  30. Bournonville C, Hénon H, Dondaine T, Delmaire C, Bombois S, Mendyk AM, Cordonnier C, Moulin S, Leclerc X, Bordet R, Lopes R. Identification of a specific functional network altered in poststroke cognitive impairment. Neurology. 2018;90(21):1879-1888. https://doi.org/10.1212/WNL.0000000000005553
  31. Debette S, Schilling S, Duperron MG, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and metaanalysis. JAMA Neurol. 2019;76:81-94.  https://doi.org/10.1001/jamaneurol.2018.3122
  32. Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.). https://doi.org/10.14412/2074-2711-2019-3S-4-17
  33. Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684-696.  https://doi.org/10.1016/S1474-4422(19)30079-1
  34. Muñoz Maniega S, Chappell FM, Valdés Hernández MC, Armitage PA, Makin SD, Heye AK, Thrippleton MJ, Sakka E, Shuler K, Dennis MS, Wardlaw JM. Integrity of normalappearing white matter: influence of age, visible lesion burden and hypertension in patients with smallvessel disease. J Cereb Blood Flow Metab. 2017;37:644-656.  https://doi.org/10.1177/0271678X16635657
  35. Benedictus MR, Hochart A, Rossi C, Boulouis G, Hénon H, van der Flier WM, Cordonnier C. Prognostic factors for cognitive decline after intracerebral hemorrhage. Stroke. 2015;46:2773-2778. https://doi.org/10.1161/STROKEAHA.115.010200
  36. Moulin S, Labreuche J, Bombois S, Rossi C, Boulouis G, Hénon H, Duhamel A, Leys D, Cordonnier C. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 2016;15:820-829.  https://doi.org/10.1016/S1474-4422(16)00130-7
  37. Garcia PY, Roussel M, Bugnicourt JM, Lamy C, Canaple S, Peltier J, Loas G, Deramond H, Godefroy O. Cognitive impairment and dementia after intracerebral hemorrhage: a cross-sectional study of a hospital based series. J Stroke. Cerebrovasc Dis. 2013;22:80-86.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.06.013
  38. Donnellan C, Werring D. Cognitive impairment before and after intracerebral haemorrhage: a systematic review. Neurol Sci. 2020;41(3):509-527.  https://doi.org/10.1007/s10072-019-04150-5
  39. Banerjee G, Wilson D, Ambler G, Osei-Bonsu Appiah K, Shakeshaft C, Lunawat S, Cohen H, Yousry T Dr, Lip GYH, Muir KW, Brown MM, Al-Shahi Salman R, Jäger HR, Werring DJ; CROMIS-2 Collaborators. Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy. Stroke. 2018;49(1):40-45.  https://doi.org/10.1161/STROKEAHA.117.019409
  40. Kulesh AA. Current approaches to diagnosing in intracerebral hemorrhage. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):4-11. (In Russ.). https://doi.org/10.14412/2074-2711-2020-2-4-11
  41. Gong L, Gu Y, Yu Q, Wang H, Zhu X, Dong Q, Xu R, Zhao Y, Liu X. Prognostic Factors for Cognitive Recovery Beyond Early Poststroke Cognitive Impairment (PSCI): A Prospective Cohort Study of Spontaneous Intracerebral Hemorrhage. Front Neurol. 2020;11:278.  https://doi.org/10.3389/fneur.2020.00278
  42. Chang TY, Huang KL, Ho MY, Ho PS, Chang CH, Liu CH, Chang YJ, Wong HF, Hsieh IC, Lee TH, Liu HL. Graph theoretical analysis of functional networks and its relationship to cognitive decline in patients with carotid stenosis. J Cereb Blood Flow Metab. 2016;36(4):808-818.  https://doi.org/10.1177/0271678X15608390
  43. Wang T, Xiao F, Wu G, Fang J, Sun Z, Feng H, Zhang J, Xu H. Impairments in Brain Perfusion, Metabolites, Functional Connectivity, and Cognition in Severe Asymptomatic Carotid Stenosis Patients: An Integrated MRI Study. Neural Plast. 2017;2017:8738714. https://doi.org/10.1155/2017/8738714
  44. Quandt F, Fischer F, Schröder J, Heinze M, Kessner SS, Malherbe C, Schulz R, Cheng B, Fiehler J, Gerloff C, Thomalla G. Normalization of reduced functional connectivity after revascularization of asymptomatic carotid stenosis. J Cereb Blood Flow Metab. 2020;40(9):1838-1848. https://doi.org/10.1177/0271678X19874338
  45. Justin BN, Turek M, Hakim AM. Heart disease as a risk factor for dementia. Clin Epidemiol. 2013;5:135-145.  https://doi.org/10.2147/CLEP.S30621
  46. Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. Pacing Clin Electrophysiol. 2015;38(2):178-186.  https://doi.org/10.1111/pace.12543
  47. Alosco ML, Spitznagel MB, Cohen R, Sweet LH, Josephson R, Hughes J, Rosneck J, Gunstad J. Better adherence to treatment recommendations in heart failure predicts improved cognitive function at a one-year follow-up. J Clin Exp Neuropsychol. 2014;36(9):956-966.  https://doi.org/10.1080/13803395.2014.957167
  48. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013;5:17.  https://doi.org/10.3389/fnagi.2013.00017
  49. Kulesh AA, Drobaha VE, Kanivec IV, Akimova IA, Monak AA. CADASIL syndrome: differential diagnosis with multiple sclerosis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119(10, vyp. 2):128-136. (In Russ.). https://doi.org/10.17116/jnevro201911910128
  50. Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.). https://doi.org/10.14412/2074-2711-2018-3-4-11
  51. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537-539.  https://doi.org/10.1212/wnl.56.4.537
  52. Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria. Stroke. 2018;49:491-497.  https://doi.org/10.1161/STROKEAHA.117.016990
  53. Charidimou A, Frosch MP, Al-Shahi Salman R, Baron JC, Cordonnier C, Hernandez-Guillamon M, Linn J, Raposo N, Rodrigues M, Romero JR, Schneider JA, Schreiber S, Smith EE, van Buchem MA, Viswanathan A, Wollenweber FA, Werring DJ, Greenberg SM. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int J Stroke. 2019;14(9):956-971.  https://doi.org/10.1177/1747493019855888
  54. Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140:1829-1850. https://doi.org/10.1093/brain/awx047
  55. Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ. Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment. Neurology. 2019;92(14):e1558-e1566. https://doi.org/10.1212/WNL.0000000000007250
  56. Kuźma E, Lourida I, Moore SF, Levine DA, Ukoumunne OC, Llewellyn DJ. Stroke and dementia risk: A systematic review and meta-analysis. Alzheimers Dement. 2018;14(11):1416-1426. https://doi.org/10.1016/j.jalz.2018.06.3061
  57. Parfenov VA. Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):61-67. (In Russ.). https://doi.org/10.14412/2074-2711-2019-3S-61-67
  58. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006-1018. https://doi.org/10.1016/S1474-4422(09)70236-4
  59. Banerjee G, Chan E, Ambler G, Wilson D, Cipolotti L, Shakeshaft C, Cohen H, Yousry T, Al-Shahi Salman R, Lip GYH, Muir KW, Brown MM, Jäger HR, Werring DJ; CROMIS‐2 Collaborators †; CROMIS‐2 Collaborators†. Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations. J Am Heart Assoc. 2020;9(1):e014537. https://doi.org/10.1161/JAHA.119.014537
  60. Banerjee G, Chan E, Ambler G, Wilson D, Cipolotti L, Shakeshaft C, Cohen H, Yousry T, Lip GYH, Muir KW, Brown MM, Jäger HR, Werring DJ; CROMIS-2 collaborators. Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA. J Neurol. 2019;266(5):1250-1259. https://doi.org/10.1007/s00415-019-09256-6
  61. Casolla B, Caparros F, Cordonnier C, Bombois S, Hénon H, Bordet R, Orzi F, Leys D. Biological and imaging predictors of cognitive impairment after stroke: a systematic review. J Neurol. 2019;266(11):2593-2604. https://doi.org/10.1007/s00415-018-9089-z
  62. Levine DA, Galecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Wadley VG. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314:41-51.  https://doi.org/10.1001/jama.2015.6968
  63. Kulesh AA, Shestakov VV. Post-stroke cognitive impairment and the possibility of treatment with cellex. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2016;116(5):38-42. (In Russ.). https://doi.org/10.17116/jnevro20161165138-42 
  64. Jokinen H, Melkas S, Ylikoski R, Pohjasvaara T, Kaste M, Erkinjuntti T, Hietanen M. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22:1288-1294. https://doi.org/10.1111/ene.12743
  65. Sexton E, McLoughlin A, Williams DJ, Merriman NA, Donnelly N, Rohde D, Hickey A, Wren MA, Bennett K. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4(2):160-171.  https://doi.org/10.1177/2396987318825484
  66. Pendlebury ST, Wadling S, Silver LE, Mehta Z, Rothwell PM. Transient cognitive impairment in TIA and minor stroke. Stroke. 2011;42:3116-3121. https://doi.org/10.1161/STROKEAHA.111.621490
  67. Casolla B, Caparros F, Cordonnier C, Bombois S, Hénon H, Bordet R, Orzi F, Leys D. Biological and imaging predictors of cognitive impairment after stroke: a systematic review. J Neurol. 2019;266(11):2593-2604. https://doi.org/10.1007/s00415-018-9089-z
  68. Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248-258.  https://doi.org/10.1016/S1474-4422(18)30442-3
  69. Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O’Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV. Vascular dysfunction — The disregarded partner of Alzheimer’s disease. Alzheimer’s Dement. 2019;15:158-156.  https://doi.org/10.1016/j.jalz.2018.07.222
  70. Bogolepova AN. The modern concept of mixed dementia. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(5):120-126. (In Russ.). https://doi.org/10.17116/jnevro201511551120-126
  71. Gottesman RF, Schneider AL, Zhou Y, Coresh J, Green E, Gupta N, Knopman DS, Mintz A, Rahmim A, Sharrett AR, Wagenknecht LE, Wong DF, Mosley TH. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA. 2017;317:1443-1450. https://doi.org/10.1001/jama.2017.3090
  72. Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC; Alzheimer’s Disease Neuroimaging Initiative. Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934. https://doi.org/10.1038/ncomms11934
  73. Levit A, Hachinski V, Whitehead SN. Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease. Geroscience. 2020;42(2):445-465.  https://doi.org/10.1007/s11357-020-00164-6
  74. Fierini F. Mixed dementia: Neglected clinical entity or nosographic artifice? J Neurol Sci. 2020;410:116662. https://doi.org/10.1016/j.jns.2019.116662
  75. Iadecola C, Gottesman RF. Neurovascular and Cognitive Dysfunction in Hypertension. Circ Res. 2019;124(7):1025-1044. https://doi.org/10.1161/CIRCRESAHA.118.313260
  76. Kulesh AA, Drobakha VE, Shestakov VV. Sporadic cerebral non-amyloid microangiopathy: pathogenesis, diagnosis, and features of treatment policy. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(4):13-22. (In Russ.). https://doi.org/10.14412/2074-2711-2018-4-13-22
  77. Uemura MT, Maki T, Ihara M, Lee VMY, Trojanowski JQ. Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia. Front Aging Neurosci. 2020;12:80.  https://doi.org/10.3389/fnagi.2020.00080
  78. Dobrynina LA, Akhmetzyanov BM, Gadzhieva ZSh, Kremneva EI, Kalashnikova LA, Krotenkova MV. The role of arterial and venous blood flow and cerebrospinal fluid flow disturbances in the development of cognitive impairments in cerebral microangiopathy. Annals of Clinical and Experimental Neurology. 2019;13(2):19-31. (In Russ.). https://doi.org/10.25692/ACEN.2019.2.3
  79. Parfenov VA, Ostroumova OD, Ostroumova TM, Kochetkov AI, Fateeva VV, Khacheva KK, Khakimova GR, Epstein OI. Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments. Neuropsychiatr Dis Treat. 2019;15:1381-1402. https://doi.org/10.2147/NDT.S197032
  80. Bogolepova AN. The role of oxidative stress in the development of vascular cognitive disorders. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2020;120(8):133-139. (In Russ.). https://doi.org/10.17116/jnevro2020120081133
  81. Kamchatnov PR, Chugunov AV, Tyazhelnikov AA, Pyshkina LI. Pathogenesis of chronic disorders of cerebral circulation. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(12. Vyp. 2):70-77. (In Russ.). https://doi.org/10.17116/jnevro201711712270-77
  82. Moroni F, Ammirati E, Rocca MA, Filippi M, Magnoni M, Camici PG. Cardiovascular disease and brain health: Focus on white matter hyperintensities. Int J Cardiol Heart Vasc. 2018;19:63-69.  https://doi.org/10.1016/j.ijcha.2018.04.006
  83. Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis. J Neuropsychol. 2015;9(1):109-136.  https://doi.org/10.1111/jnp.12039
  84. Wallin A, Román GC, Esiri M, Kettunen P, Svensson J, Paraskevas GP, Kapaki E. Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease. J Alzheimers Dis. 2018;62(3):1417-1441. https://doi.org/10.3233/JAD-170803
  85. Barbay M, Taillia H, Nedelec-Ciceri C, Arnoux A, Puy L, Wiener E, Canaple S, Lamy C, Godefroy O, Roussel M; GRECOGVASC Study Group. Vascular cognitive impairment: Advances and trends. Rev Neurol (Paris). 2017;173(7-8):473-480.  https://doi.org/10.1016/j.neurol.2017.06.009
  86. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220-2241. https://doi.org/10.1161/01.STR.0000237236.88823.47
  87. Ramirez-Gomez L, Zheng L, Reed B, Kramer J, Mungas D, Zarow C, Vinters H, Ringman JM, Chui H. Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort. Dement Geriatr Cogn Disord. 2017;44(1-2):1-11.  https://doi.org/10.1159/000477344
  88. Oldenbeuving AW, de Kort PL, Jansen BP, Algra A, Kappelle LJ, Roks G. Delirium in the acute phase after stroke: incidence, risk factors, and outcome. Neurology. 2011;76:993-999.  https://doi.org/10.1212/WNL.0b013e318210411f
  89. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol. 2013;12:822-838.  https://doi.org/10.1016/S1474-4422(13)70124-8
  90. Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O’Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2018;14(3):280-292.  https://doi.org/10.1016/j.jalz.2017.09.007
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.